50 Endocrine Myths

Fatigue is one of the most common symptoms patients attribute to thyroid dysfunction, but it is highly nonspecific. Studies show that 70% of people with normal thyroid function report at least one symptom commonly associated with hypothyroidism.

• Fatigue has dozens of potential causes including sleep disorders, depression, anemia, and vitamin deficiencies.
• No single symptom can reliably identify patients with thyroid disease—blood tests are required.
• Many patients with confirmed hypothyroidism are actually asymptomatic.

Soy has been unfairly blamed for causing thyroid dysfunction. Meta-analyses of randomized controlled trials show soy supplementation has no significant effect on thyroid hormone levels (T3 and T4).

• Soy only very modestly raises TSH levels, with unclear clinical significance.
• Healthy individuals with adequate iodine intake can safely consume soy.
• Soy may slightly reduce levothyroxine absorption, so take thyroid medication separately from soy foods.

Broccoli, cauliflower, kale, and other cruciferous vegetables are often unnecessarily restricted in patients with thyroid conditions.

• Avoidance of cruciferous vegetables has little proven benefit in patients with thyroid disorders.
• These vegetables would need to be consumed in extremely large amounts to affect thyroid function.
• The nutritional benefits of cruciferous vegetables far outweigh theoretical thyroid concerns.

Desiccated thyroid extract (from pig thyroid) is often marketed as more "natural," but this doesn't mean it's superior or safer.

• Randomized trials show no significant quality of life improvement with desiccated thyroid over levothyroxine.
• Desiccated thyroid contains a T4:T3 ratio of 4.2:1, much lower than the human ratio of 14:1, causing supraphysiological T3 levels.
• There are substantially more safety and efficacy data supporting synthetic levothyroxine.

Subclinical hypothyroidism (elevated TSH with normal T4) affects up to 10% of adults, but most do not benefit from treatment.

• Clinical guidelines now recommend against routine treatment for most adults with subclinical hypothyroidism.
• Large trials show levothyroxine does not improve quality of life, symptoms, or cognitive function in older adults.
• TSH naturally rises with age and what appears "elevated" may be normal for older individuals.

While iodine is essential for thyroid hormone production, most people in developed countries get adequate iodine from their diet.

• Excess iodine can actually cause thyroid dysfunction, including both hypothyroidism and hyperthyroidism.
• Iodine supplementation programs have been associated with increased thyroid autoimmunity.
• Only those with documented iodine deficiency should take iodine supplements.

Over-the-counter thyroid supplements are unregulated and may contain actual thyroid hormones or harmful ingredients.

• Many supplements marketed for thyroid health have no proven benefit.
• Some "thyroid support" products have been found to contain undisclosed thyroid hormones.
• Ashwagandha, vitamin B12, and other popular supplements have little to no evidence of thyroid benefit.

While lifestyle changes are crucial, type 2 diabetes is a chronic, progressive condition that often requires medication.

• Lifestyle modification is the foundation of diabetes management but may not be sufficient alone.
• Beta cell function continues to decline over time in most patients.
• Medications, including insulin, are tools to protect your health, not signs of failure.

The relationship between diet and diabetes is far more complex than simply "sugar causes diabetes."

• Type 2 diabetes results from insulin resistance and beta cell dysfunction, influenced by genetics, obesity, and lifestyle.
• Overall dietary pattern, caloric intake, and body weight matter more than sugar intake alone.
• Type 1 diabetes is an autoimmune condition completely unrelated to sugar consumption.

While metabolic adaptation occurs with weight loss, it doesn't mean your metabolism is permanently damaged.

• Metabolic adaptation (reduced energy expenditure after weight loss) is a normal physiological response.
• This adaptation is largely reversible when weight stabilizes.
• Metabolic adaptation does not predict weight regain at one-year follow-up.

Obesity is a complex disease involving genetics, hormones, environment, and behavior—not simply a "slow metabolism."

• People with obesity actually have higher absolute metabolic rates due to greater body mass.
• Hormonal factors like leptin resistance, insulin, and gut hormones play important roles.
• Obesity is now recognized as a chronic disease requiring comprehensive treatment.

The 2002 Women's Health Initiative results were misinterpreted, causing millions of women to unnecessarily stop hormone therapy.

• When started within 10 years of menopause, hormone therapy reduces all-cause mortality and coronary disease risk.
• The WHI studied older women (average age 63) starting hormone therapy many years after menopause.
• For younger, recently menopausal women with symptoms, the benefit-risk ratio is generally favorable.

The term "bioidentical" is often used as a marketing term implying safety that isn't supported by evidence.

• Bioidentical hormones (estradiol, micronized progesterone) are available by prescription.
• Compounded "bioidentical" hormones are not regulated and lack safety and efficacy data.
• There is no evidence that compounded bioidentical hormones are safer than approved products.

Compounding pharmacies often claim to create personalized hormone formulations, but this customization lacks scientific basis.

• Salivary hormone testing used to "customize" doses is not validated for this purpose.
• Compounded products have variable potency and quality due to lack of regulation.
• Approved hormone therapies come in multiple doses and formulations for individualization.

Early concerns about cardiovascular risk with testosterone have been largely addressed by recent large trials.

• The TRAVERSE trial showed testosterone treatment does not increase the risk of major cardiovascular events.
• Testosterone may increase the risk of pulmonary embolism and atrial fibrillation.
• Cardiovascular safety should still be monitored, especially in high-risk patients.

Many symptoms attributed to "low T" are nonspecific and may have other causes.

• Fatigue, decreased energy, and mood changes have many potential causes beyond testosterone.
• Testosterone levels should only be measured in men with specific symptoms of hypogonadism.
• Obesity and chronic diseases often cause low testosterone—treating the underlying condition may restore levels.

"Adrenal fatigue" is not recognized by any endocrinology society and has no scientific basis.

• The adrenal glands do not become "fatigued" from chronic stress.
• True adrenal insufficiency is a serious, rare condition with specific diagnostic criteria.
• Symptoms attributed to "adrenal fatigue" (fatigue, sleep problems, cravings) have many other causes.

Salivary cortisol testing marketed for "adrenal fatigue" is not validated for this purpose.

• Cortisol levels naturally fluctuate throughout the day.
• Low cortisol on a single saliva test does not diagnose adrenal insufficiency.
• True adrenal insufficiency requires specific blood tests and stimulation testing.

Over-the-counter "adrenal support" supplements are unregulated and potentially dangerous.

• Some adrenal supplements contain actual adrenal hormones that can suppress your own adrenal function.
• There is no evidence these supplements improve energy or treat fatigue.
• Taking adrenal hormones without medical supervision can cause serious harm.

Saliva testing is heavily marketed by alternative medicine practitioners but has significant limitations for most hormones.

• Salivary hormone levels do not reliably reflect tissue hormone activity or clinical status.
• Saliva testing is not validated for diagnosing most endocrine disorders or guiding treatment.
• Blood testing remains the gold standard for measuring most hormones including thyroid, cortisol, and sex hormones.

24-hour urine hormone testing and dried urine tests are promoted as comprehensive hormone assessments but have limited clinical utility.

• Urine hormone metabolites do not directly reflect active hormone levels in tissues.
• These tests are not validated for diagnosing hormone deficiencies or guiding hormone replacement therapy.
• Urine testing is useful only for specific conditions like pheochromocytoma and some adrenal disorders but not routine hormone assessment.

Some practitioners claim urine metabolite testing can detect subtle hormone problems missed by standard blood tests.

• There is no evidence that urine metabolite patterns predict symptoms or guide treatment better than blood tests.
• The clinical significance of various hormone metabolite ratios is unproven.
• Standard blood tests, when properly interpreted, provide the information needed for diagnosis and treatment.

While exercise has numerous health benefits, it's relatively ineffective for weight loss without dietary changes.

• Exercise typically produces modest weight loss (2-3 kg) without dietary modification.
• The body compensates for increased activity by reducing non-exercise energy expenditure.
• Exercise is crucial for weight maintenance and metabolic health, but diet drives weight loss.

Weight regain is driven by powerful biological mechanisms, not personal weakness.

• Hormones that increase hunger (ghrelin) rise after weight loss, while satiety hormones decrease.
• Metabolic rate drops disproportionately after weight loss, persisting for years.
• The body has multiple redundant systems designed to defend against weight loss.

Obesity is a complex chronic disease involving genetics, hormones, environment, and neurobiology.

• Over 100 genetic variants influence body weight and fat distribution.
• Hormonal factors including leptin, insulin, and gut hormones regulate appetite and metabolism.
• Environmental factors like food availability, sleep, stress, and medications all contribute.

Calcium supplements are not beneficial for most people and may carry risks.

• Meta-analyses show calcium supplements do not prevent fractures in community-dwelling adults.
• Calcium supplements may increase the risk of kidney stones and possibly cardiovascular events.
• Dietary calcium from food sources is preferred over supplements.

Vitamin D supplementation has been oversold, and high doses may actually be harmful.

• Large trials show vitamin D supplementation does not prevent fractures, cancer, or heart disease in vitamin D-replete individuals.
• High-dose vitamin D has been associated with increased falls and fractures in some studies.
• Supplementation should target those with true deficiency, not the general population.

Observational studies linking low vitamin D to various diseases have not been confirmed by randomized trials.

• Low vitamin D levels may be a marker of poor health rather than a cause.
• Randomized trials of vitamin D supplementation have been largely negative for most outcomes.
• Vitamin D supplementation may reduce cancer mortality but not cancer incidence.

PCOS is the most common cause of ovulatory infertility, but most women with PCOS can conceive with treatment.

• Ovulation induction with medications like letrozole or clomiphene is effective for most women with PCOS.
• Weight loss can restore ovulation in many women with PCOS and obesity.
• Many women with PCOS conceive naturally, especially those with milder phenotypes.

PCOS affects women of all body types, though obesity can worsen symptoms.

• Up to 30-50% of women with PCOS are not overweight.
• Lean women with PCOS can still have insulin resistance and metabolic abnormalities.
• PCOS is primarily a hormonal disorder, not a weight related condition.

Effective treatments exist for menopausal symptoms, and suffering is not necessary.

• Hormone therapy is highly effective for hot flashes and other vasomotor symptoms.
• Non-hormonal options are available for women who cannot or prefer not to use hormones.
• Untreated severe menopausal symptoms can significantly impact quality of life and health.

The relationship between hormone therapy and breast cancer is more nuanced than commonly believed.

• Estrogen-only therapy (for women without a uterus) does not increase breast cancer risk.
• Combined estrogen-progestogen therapy has a small increased risk after 5+ years of use.
• The absolute risk increase is small, about 1 additional case per 1,000 women per year.

While more common with age, erectile dysfunction often signals underlying health problems.

• Erectile dysfunction can be an early warning sign of cardiovascular disease, appearing 2 to 3 years before cardiac symptoms.
• 30% of men with erectile dysfunction have previously undiagnosed endocrine or metabolic disorders.
• Treatable causes include low testosterone, diabetes, thyroid disorders, and hyperprolactinemia.

Endocrine-disrupting chemicals can have effects at very low doses, sometimes lower than pharmaceutical drugs.

• EDCs can act at nanogram concentrations because they mimic hormones that work at very low levels.
• The timing of exposure (especially during fetal development) may matter more than the dose.
• Effects may not appear until years or decades after exposure.

Products labeled "natural" or "organic" can still contain endocrine-disrupting chemicals.

• Essential oils and plant-based products can have hormonal effects.
• Lavender and tea tree oils have been associated with gynecomastia in boys.
• "Natural" does not mean hormone-free or safe for the endocrine system.

Many herbal supplements can affect hormone levels and interact with endocrine medications.

• Some supplements contain undisclosed hormones or hormone-like compounds.
• Herbal products can interfere with thyroid medication absorption and metabolism.
• "Natural" does not mean safe, many potent drugs and toxins come from plants.

While reducing refined carbohydrates can help, extreme carbohydrate restriction is not necessary and may have drawbacks.

• Low-carbohydrate diets improve glycemic control and hyperinsulinemia, but insulin sensitivity may actually worsen without weight loss.
• Both very low-carbohydrate diets (40% energy) and very high-carbohydrate diets (>70% energy) are associated with increased mortality.
• The quality of carbohydrates matters more than total amount, replacing processed carbohydrates with whole grains and fiber is beneficial.

While insulin resistance increases diabetes risk, progression is not inevitable and can often be prevented or delayed.

• Lifestyle modification with diet and exercise can prevent or delay type 2 diabetes by 58% in high-risk individuals.
• Many people with insulin resistance never develop diabetes, especially with appropriate interventions.
• Insulin resistance is reversible with weight loss, physical activity and sometimes medication.

Insulin resistance typically develops silently over years without obvious symptoms, making it impossible to detect by how you feel.

• Insulin resistance can be present for a decade or more before blood sugar levels become abnormal.
• Symptoms like fatigue and weight gain are nonspecific and cannot reliably identify insulin resistance.
• Blood tests are required to detect insulin resistance. You cannot diagnose it based on symptoms alone.

Female sexual desire is complex and influenced by many factors beyond testosterone levels.

• Serum testosterone levels have not been consistently associated with sexual function in postmenopausal women.
• Relationship factors, mental health, physical health, and medications often contribute more to sexual function than hormone levels.
• A blood testosterone level should not be used to diagnose low sexual desire, clinical assessment is required.

Unlike in men, testosterone testing has limited utility for diagnosing sexual problems in women.

• There is no particular testosterone level or lower limit that is diagnostic of decreased female sexual function.
• Routine testing of testosterone levels outside of therapy monitoring has no proven clinical utility and is not recommended.
• Female sexual dysfunction requires a comprehensive biopsychosocial assessment, not just hormone testing.

DHEA (dehydroepiandrosterone) is widely marketed for sexual health, but evidence for benefit is weak.

• Systemic DHEA has not shown efficacy for treating sexual dysfunction in postmenopausal women with normal adrenal function.
• Meta-analyses show DHEA provides only minimal improvement in libido with no significant effect on overall sexual function.
• DHEA is associated with androgenic side effects including acne without clear sexual health benefits.

Sexual function in women involves complex interactions between biological, psychological, and social factors.

• Relationship difficulties, stress, past trauma, and cultural beliefs all significantly impact female sexual function.
• Depression and antidepressant medications are independently associated with sexual dysfunction.
• Effective treatment often requires psychological interventions, not just hormones.

While testosterone may help sexual desire, evidence does not support its use for other symptoms in women.

• Available data show no effect of testosterone therapy on general wellbeing in postmenopausal women.
• There is insufficient evidence to support testosterone for enhancing cognitive performance or delaying cognitive decline.
• A randomized trial found testosterone was not more effective than placebo for improving depression, fatigue, or sexual dysfunction in women with treatment-resistant depression.

Testosterone pellets and injections are not recommended for women due to safety concerns and lack of evidence.

• Pellets and injections result in supraphysiological (higher than normal) testosterone concentrations.
• Unlike creams or patches, pellets cannot be easily removed if side effects occur—they dissolve over 3-6 months.
• Global consensus guidelines specifically recommend against pellets, injections, or any formulation causing supraphysiological levels.

While generally well-tolerated at physiological doses, testosterone can cause androgenic side effects in women.

• Testosterone therapy is associated with increased acne and facial/body hair growth in some women.
• Virilizing effects including voice deepening and clitoral enlargement can occur and may be irreversible.
• Long-term safety data are lacking. Most studies have not evaluated use beyond 6 months.

Testosterone therapy is only indicated for a specific subset of women after comprehensive evaluation.

• The only evidence-based indication for testosterone in women is hypoactive sexual desire disorder (HSDD) in postmenopausal women.
• Other causes of low desire (relationship issues, depression, medications, medical conditions) must be identified and addressed first.
• There is insufficient evidence to recommend testosterone for premenopausal women with low desire.

Compounded testosterone preparations lack the quality control and safety data of regulated products.

• Compounded products have variable potency and quality due to lack of regulation.
• Salivary hormone testing used to "customize" compounded doses is not validated for this purpose.
• Global consensus guidelines recommend against compounded testosterone unless no approved equivalent is available.

The relationship between perceived stress and cortisol is far more complex than commonly believed. Many people assume that feeling stressed automatically translates to elevated cortisol, but research shows this is often not the case.

• Perceived stress measured by questionnaires is inconsistently associated with actual cortisol levels, studies show they often do not correlate.
• Chronic stress can actually lead to blunted cortisol responses over time, not elevated levels, as the HPA axis adapts.
• Subjective stress and cortisol responses often show a lack of coherence. Your mind and your hormones may tell different stories.

Cortisol testing is often marketed as a way to objectively measure your stress levels, but this is a misuse of the test with significant limitations.

• Cortisol levels fluctuate dramatically throughout the day, with normal variations of 10-fold or more from morning to evening.
• A single cortisol measurement cannot distinguish between normal daily variation and stress-related changes.
• Cortisol testing is validated for diagnosing specific medical conditions (Cushing's syndrome, adrenal insufficiency) but not for quantifying psychological stress.